AOD9604 6 mg

Subtotal	$0.00
Shipping	$0.00
Total	$0.00

AOD9604 6 mg - Peptide Sciences USA Research Peptides

Active Substance: Anti-Obesity Drug-9604
Concentration: 6 mg per vial
Pack Size: Single vial (lyophilized powder)
Manufacturer: Peptide Sciences USA
Brand Name: AOD9604
Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂
Molecular Weight: 1815.08 g/mol
Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Synonyms: hGH Fragment 177-191, Anti-Obesity Peptide

Manufacturer	Peptide Sciences USA
Brand	AOD9604
Substance	Anti-Obesity Drug-9604
Concentration	6 mg
Pack Size	vial

Out of Stock

Research Peptides Description

AOD9604 6 mg – Transform Fat Loss Research

Product Summary

Imagine unlocking the potential of targeted fat loss, where excess weight melts away without compromising muscle mass. AOD9604 6 mg vial from Peptide Sciences USA, a synthetic peptide derived from human growth hormone, offers this possibility. Designed to stimulate fat metabolism, AOD9604 is a powerful tool for researchers exploring innovative solutions for weight loss and metabolic health.

How AOD9604 Works

AOD9604, known as Anti-Obesity Drug-9604, is a 16-amino-acid peptide corresponding to the C-terminal fragment of human growth hormone (hGH 177-191) with the sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe. It mimics hGH's fat-burning properties without affecting growth or insulin levels. AOD9604 activates lipolysis (fat breakdown) by stimulating beta-3 adrenergic receptors in adipose tissue, increasing fat oxidation. It also inhibits lipogenesis, preventing new fat cell formation.

Clinical studies have shown AOD9604's efficacy in promoting fat loss. In obese mice, it reduced body fat by up to 40% over 14 days without significant side effects. Human trials reported a 2-3 kg fat loss over 12 weeks with subcutaneous injections, particularly targeting abdominal fat. Unlike full hGH, AOD9604 has minimal impact on muscle growth or blood sugar, making it a focused tool for fat loss research. Its molecular weight (1815.08 g/mol) supports stability in injectable formulations.

Why Choose AOD9604?

AOD9604 is a breakthrough for fat loss research, offering targeted benefits that redefine metabolic studies. Here's why it stands out:

Effective Fat Loss: Stimulates lipolysis, reducing body fat by up to 40% in preclinical studies, particularly in stubborn areas like the abdomen.
Metabolic Support: Inhibits fat cell formation, promoting a leaner physique without affecting muscle mass.
Minimal Side Effects: Unlike hGH, AOD9604 avoids impacting growth or insulin levels, ensuring a focused research profile.
Rapid Results: Demonstrated significant fat reduction in as little as 14 days in animal models, accelerating research outcomes.
High Purity: Peptide Sciences USA guarantees 99% purity through advanced synthesis, ensuring reliable research results.

AOD9604 6 mg empowers researchers to explore innovative fat loss solutions, backed by robust scientific data.

Product Specifications

Peptide Sciences USA's AOD9604 6 mg vial is designed for precision in fat loss research, offering unmatched quality. Here's the breakdown:

Composition: Contains 6 mg of Anti-Obesity Drug-9604 (C₇₈H₁₂₃N₂₃O₂₃S₂, molecular weight 1815.08 g/mol), a hGH fragment.
Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous injection.
Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
Usage Guidelines: Reconstitute with bacteriostatic water and administer subcutaneously, typically at 200–300 mcg daily in research protocols. Use under professional supervision.
Storage: Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
Safety: Human trials report mild side effects like headache or injection site reactions. Long-term safety data is limited, requiring research oversight.

This peptide is for research purposes only, offering a reliable platform for studying fat metabolism and weight loss.

Legal Disclaimer

AOD9604 6 mg is supplied for research purposes only and is not FDA-approved for human use. It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical and clinical research.

Frequently Asked Questions

What does AOD9604 do?

AOD9604 is a peptide that stimulates fat breakdown (lipolysis) and inhibits fat cell formation (lipogenesis). It targets adipose tissue, particularly abdominal fat, making it a valuable tool for researching weight loss and metabolic health.

Does AOD 9604 work for weight loss?

Yes, AOD9604 has shown efficacy in fat loss research. Studies in obese mice demonstrated up to 40% fat reduction in 14 days, and human trials reported 2-3 kg fat loss over 12 weeks with subcutaneous injections, particularly effective for abdominal fat.

How long does it take for an AOD 9604 to work?

In preclinical studies, AOD9604 reduced fat mass within 14 days. Human trials showed noticeable fat loss within 4–12 weeks, depending on dosage and protocol, making it effective for short- to medium-term research.

What is the difference between AOD 9604 and BPC 157?

AOD9604 is a hGH fragment focused on fat loss through lipolysis and lipogenesis inhibition, targeting adipose tissue. BPC 157, a gastric pentadecapeptide, promotes healing and tissue repair, with broader applications in muscle and wound recovery research.

How to take AOD9604 6 mg?

AOD9604 is supplied as a 6 mg lyophilized powder. Reconstitute with bacteriostatic water and administer subcutaneously, typically at 200–300 mcg daily in research protocols. Always follow professional research guidelines.